Awan FT, Yande S, Esterberg L, Nagar SP, Goyal RK, Priyadarshini M. Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): a SEER-Medicare analysis. Poster presented at the ASCO Quality Care Symposium 2023; October 27, 2023. Boston, MA. [abstract] JCO Oncol Pract. 2023 Nov 1; 19(11 Suppl):23-4. doi: 10.1200/OP.2023.19.11_suppl.24
Gnanasakthy A, Norcross L, Clark M, Fitzgerald K. A review of patient-reported outcome considerations in oncologic drug advisory committee meetings (2016-2021). JCO Oncol Pract. 2023 May;19(5):e745-62. doi: 10.1200/OP.22.00774
Hill NL, Mogle J, Bhargava S, Bell TR, Bhang I, Katz M, Sliwinski MJ. Longitudinal relationships among depressive symptoms and three types of memory self-report in cognitively intact older adults. Int Psychogeriatr. 2020 Jun;32(6):719-32. doi: 10.1017/S104161021900084X
Hill NL, McDermott C, Mogle J, Munoz E, DePasquale N, Wion R, Whitaker E. Subjective cognitive impairment and quality of life: a systematic review. Int Psychogeriatr. 2017 Dec;29(12):1965-77.